Your browser doesn't support javascript.
loading
Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice.
Tilstam, Pathricia V; Soppert, Josefin; Hemmers, Christian; Harlacher, Eva; Döring, Yvonne; van der Vorst, Emiel P C; Schulte, Corinna; Alampour-Rajabi, Setareh; Theelen, Wendy; Asare, Yaw; de Winther, Menno P J; Lawrence, Toby; Bernhagen, Jürgen; Schober, Andreas; Zernecke, Alma; Jankowski, Joachim; Weber, Christian; Noels, Heidi.
  • Tilstam PV; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany; Yale University School of Medicine, Internal Medicine-Rheumatology Department, New Haven, CT, USA.
  • Soppert J; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Hemmers C; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Harlacher E; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Döring Y; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Germany.
  • van der Vorst EPC; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, Germany; Department of Pathology, Car
  • Schulte C; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Alampour-Rajabi S; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Theelen W; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.
  • Asare Y; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany; Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
  • de Winther MPJ; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Germany; Department of Medical Biochemistry, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands.
  • Lawrence T; Centre d'Immunologie de Marseille-Luminy, Aix-Marseille Université, France.
  • Bernhagen J; Chair of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig-Maximilians-University (LMU), Munich, Germany; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany; Munich Cluster for Systems Neurology (Sy
  • Schober A; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Germany.
  • Zernecke A; Institute of Experimental Biomedicine, University Hospital Würzburg, Germany.
  • Jankowski J; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany; Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, the Netherlands.
  • Weber C; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Germany; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical
  • Noels H; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany. Electronic address: hnoels@ukaachen.de.
Atherosclerosis ; 292: 23-30, 2020 01.
Article en En | MEDLINE | ID: mdl-31733453

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Quinasa I-kappa B Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Quinasa I-kappa B Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article